Adherence to Global Health Recommendations Cuts Risk for Some Cancers
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, July 18, 2023 -- Greater adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations is associated with a lower risk for breast, colorectal, and lung cancers, according to a study published online June 13 in Cancer.
Fiona C. Malcomson, Ph.D., from Newcastle University in the United Kingdom, and colleagues conducted a systematic literature review to identify studies examining adherence to the 2018 Cancer Prevention Recommendations and cancer risk.
Based on 18 included studies, the researchers found the summary risk ratio per 1-point increment in adherence score was 0.89 (I² = 76.5 percent; seven studies) for breast cancer, 0.88 (I² = 26.2 percent; four studies) for colorectal cancer, and 0.92 (I² = 66.0 percent; two studies) for lung cancer. For prostate or other cancers, there were no significant associations observed.
"The evidence supporting the influence of lifestyle factors is particularly robust for certain types of cancer," Malcomson said in a statement. "For instance, consuming excessive amounts of red and processed meat has been linked to an increased risk of bowel cancer, while alcohol consumption has been associated with higher risks of cancers such as breast, bowel, and esophageal."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Nudging Both Clinicians, Patients May Increase Serious Illness Conversations
TUESDAY, July 2, 2024 -- Combining clinician- and patient-directed nudges may help to promote serious illness conversations (SICs) in cancer care, according to a study published...
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
Racial Differences Seen in Financial Hardship Among Older Cancer Survivors
MONDAY, July 1, 2024 -- Income and area-level disadvantage are the largest contributors to racial differences in financial hardship among older U.S. adults with cancer, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.